1 Day
Source:
بوابة أخبار اليوم
Europe praises new vision restoring chip
Science Corp, an American company, has launched its new device "Prima" in Europe. It is the first commercial product that implants an electronic chip behind the retina to help restore some vision in patients with age-related macular degeneration. The device aims to improve the ability to distinguish letters, numbers, and words, representing a significant advancement in the treatment of retinal diseases that cause blindness. Clinical results have shown improvement in the visual ability of 26 out of 32 study participants. The device has received European approval (CE mark), and the company expects to begin wider use starting in early 2026, with plans to implant it in a larger number of patients across Europe and the United States.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)